Showing 1-20 of 46 results
Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Cancer Agency affiliated with British Columbia Children's Hospital, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Children's Hospital affiliated with British Columbia Cancer Agency, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Calgary, AB
Institution: Alberta Children's Hospital affiliated with University of Calgary

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Children's Hospital affiliated with British Columbia Cancer Agency, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Winnipeg, MB
Institution: CancerCare Manitoba

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Sunnybrook Health Sciences Centre

This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Late Effects After High Risk Neuroblastoma – The LEAHRN Study Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Montreal, QC
Institution: CHU Sainte Justine

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Montreal, QC
Institution: McGill University Health Center, Montreal Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

North American Consortium for Histiocytosis (NACHO) Member
Funded: 07-01-2014 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

Stand Up To Cancer-St. Baldrick’s Foundation Dream Team
Funded: 07-01-2013 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: The University of British Columbia affiliated with British Columbia Cancer Agency, British Columbia Children's Hospital

This institution is a member of the Stand Up To Cancer-St. Baldrick’s Foundation Dream Team. For a description of this project, see the consortium grant made to the lead institution: The Children's Hospital of Philadelphia, Philadelphia, PA.

Stand Up To Cancer-St. Baldrick’s Foundation Dream Team
Funded: 07-01-2013 through 06-30-2017
Funding Type: Consortium Research Grant
Institution Location: Toronto, ON
Institution: Hospital for Sick Children

This institution is a member of the Stand Up To Cancer-St. Baldrick’s Foundation Dream Team. For a description of this project, see the consortium grant made to the lead institution: The Children's Hospital of Philadelphia, Philadelphia, PA.

PBMTC Late Effects Consortium Member
Funded: 07-01-2013 through 09-30-2017
Funding Type: Consortium Research Grant
Institution Location: Montreal, QC
Institution: CHU Sainte Justine

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Issai Vanan M.D., M.P.H.
Funded: 07-01-2012 through 06-30-2017
Funding Type: St. Baldrick's Scholar
Institution Location: Winnipeg, MB
Institution: CancerCare Manitoba

Based on progress to date, Dr. Vanan, was awarded a new grant in 2016 to fund an additional year of this Scholar award. Issai Vanan, M.D., M.P.H., studies medulloblastoma, the most common malignant brain tumor in children. High-risk medulloblastoma patients have low disease-free survival. Radiotherapy used in its treatment has significant long-term side-effects and new therapeutic strategies are needed that will minimize these side effects. The goals of this project are to validate and study the clinical importance of genes that may play a role in radiation resistance of medulloblastomas. Dr. Vanan hopes to identify new therapeutic targets/drugs that are therapeutic while using much lower doses of radiation, thereby reducing the negative side effects of radiotherapy. A portion of the grant was named in loving memory of Fr. Peter J. McKenna, beloved brother of former St. Baldrick's board member John McKenna, and in honor of John's incredible dedication and service. Awarded at The Feinstein Institute for Medical Research and transferred to CancerCare Manitoba.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2011 through 06-30-2016
Funding Type: Consortium Research Grant
Institution Location: Calgary, AB
Institution: Alberta Children's Hospital affiliated with University of Calgary

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2011 through 06-30-2016
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Children's Hospital affiliated with British Columbia Cancer Agency, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2011 through 06-30-2016
Funding Type: Consortium Research Grant
Institution Location: Winnipeg, MB
Institution: CancerCare Manitoba

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.